263 related articles for article (PubMed ID: 24841204)
1. Histone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses.
Yang X; Hegde VL; Rao R; Zhang J; Nagarkatti PS; Nagarkatti M
J Biol Chem; 2014 Jul; 289(27):18707-18. PubMed ID: 24841204
[TBL] [Abstract][Full Text] [Related]
2. Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120.
Chen W; Kaplan BL; Pike ST; Topper LA; Lichorobiec NR; Simmons SO; Ramabhadran R; Kaminski NE
J Leukoc Biol; 2012 Nov; 92(5):1093-102. PubMed ID: 22899554
[TBL] [Abstract][Full Text] [Related]
3. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
[TBL] [Abstract][Full Text] [Related]
4. Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.
Lombard C; Hegde VL; Nagarkatti M; Nagarkatti PS
J Pharmacol Exp Ther; 2011 Nov; 339(2):607-17. PubMed ID: 21831965
[TBL] [Abstract][Full Text] [Related]
5. RNA-seq Analysis of δ9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation.
Yang X; Bam M; Nagarkatti PS; Nagarkatti M
J Biol Chem; 2016 Jul; 291(30):15460-72. PubMed ID: 27268054
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA AW112010 Promotes the Differentiation of Inflammatory T Cells by Suppressing IL-10 Expression through Histone Demethylation.
Yang X; Bam M; Becker W; Nagarkatti PS; Nagarkatti M
J Immunol; 2020 Aug; 205(4):987-993. PubMed ID: 32690657
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of Δ
Mohammed A; Alghetaa HK; Zhou J; Chatterjee S; Nagarkatti P; Nagarkatti M
Br J Pharmacol; 2020 Nov; 177(22):5078-5095. PubMed ID: 32754917
[TBL] [Abstract][Full Text] [Related]
8. Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol.
Lu H; Kaplan BL; Ngaotepprutaram T; Kaminski NE
J Leukoc Biol; 2009 Feb; 85(2):322-9. PubMed ID: 18988696
[TBL] [Abstract][Full Text] [Related]
9. Chronic Δ⁸-THC Exposure Differently Affects Histone Modifications in the Adolescent and Adult Rat Brain.
Prini P; Penna F; Sciuccati E; Alberio T; Rubino T
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28976920
[TBL] [Abstract][Full Text] [Related]
10. Δ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8.
Sido JM; Yang X; Nagarkatti PS; Nagarkatti M
J Leukoc Biol; 2015 Apr; 97(4):677-88. PubMed ID: 25713087
[TBL] [Abstract][Full Text] [Related]
11. Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex.
Prini P; Rusconi F; Zamberletti E; Gabaglio M; Penna F; Fasano M; Battaglioli E; Parolaro D; Rubino T
J Psychiatry Neurosci; 2018 Mar; 43(2):87-101. PubMed ID: 29481316
[TBL] [Abstract][Full Text] [Related]
12. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.
McKallip RJ; Nagarkatti M; Nagarkatti PS
J Immunol; 2005 Mar; 174(6):3281-9. PubMed ID: 15749859
[TBL] [Abstract][Full Text] [Related]
13. The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses.
Klein TW; Newton CA; Widen R; Friedman H
J Immunopharmacol; 1985; 7(4):451-66. PubMed ID: 3003204
[TBL] [Abstract][Full Text] [Related]
14. Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events.
Karmaus PW; Chen W; Kaplan BL; Kaminski NE
J Neuroimmune Pharmacol; 2012 Dec; 7(4):843-55. PubMed ID: 21789506
[TBL] [Abstract][Full Text] [Related]
15. Delta 9-tetrahydrocannabinol selectively inhibits T-cell dependent humoral immune responses through direct inhibition of accessory T-cell function.
Schatz AR; Koh WS; Kaminski NE
Immunopharmacology; 1993; 26(2):129-37. PubMed ID: 8282537
[TBL] [Abstract][Full Text] [Related]
16. Marijuana-derived Δ-9-tetrahydrocannabinol suppresses Th1/Th17 cell-mediated delayed-type hypersensitivity through microRNA regulation.
Sido JM; Jackson AR; Nagarkatti PS; Nagarkatti M
J Mol Med (Berl); 2016 Sep; 94(9):1039-51. PubMed ID: 27038180
[TBL] [Abstract][Full Text] [Related]
17. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway.
Zhu LX; Sharma S; Stolina M; Gardner B; Roth MD; Tashkin DP; Dubinett SM
J Immunol; 2000 Jul; 165(1):373-80. PubMed ID: 10861074
[TBL] [Abstract][Full Text] [Related]
18. Relationship of aging and cytokines to the immunomodulation by delta-9-tetrahydrocannabinol on murine lymphoid cells.
Snella E; Pross S; Friedman H
Int J Immunopharmacol; 1995 Dec; 17(12):1045-54. PubMed ID: 8964654
[TBL] [Abstract][Full Text] [Related]
19. Role of histone modifications in marking and activating genes through mitosis.
Valls E; Sánchez-Molina S; Martínez-Balbás MA
J Biol Chem; 2005 Dec; 280(52):42592-600. PubMed ID: 16199528
[TBL] [Abstract][Full Text] [Related]
20. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
